Tuberculosis vaccine - HanaVax
Latest Information Update: 02 Oct 2021
At a glance
- Originator HanaVax
- Class Peptide vaccines; Synthetic vaccines; Tuberculosis vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Tuberculosis
Most Recent Events
- 09 Mar 2021 Early research in Tuberculosis (Prevention) in Japan (Intranasal) (HanaVax pipeline, March 2021)